Skip to main content
hello world

Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.

Stocks in play: CareRx Corporation

Baystreet - Thu Aug 8, 8:52AM CDT

Today reported its financial results for the second quarter ended June 30, 2024. Revenue for the quarter was $92.0 million as compared to $89.7 million for the first quarter of 2024 and $94.5 million for the second quarter of 2023. Net loss for the quarter was $1.4 million as compared to a net loss of $0.5 million for the first quarter of 2024 and net income of $1.9 million for the second quarter of 2023. CareRx Corporation shares T.CRRX are trading unchanged at $2.22.